Gradient Investments LLC Buys 15,852 Shares of The Procter & Gamble Company (NYSE:PG)

Gradient Investments LLC lifted its position in shares of The Procter & Gamble Company (NYSE:PG) by 7.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 226,874 shares of the company’s stock after acquiring an additional 15,852 shares during the quarter. Gradient Investments LLC’s holdings in Procter & Gamble were worth $37,416,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Advantage Trust Co bought a new stake in Procter & Gamble during the fourth quarter valued at $28,000. Naples Money Management LLC acquired a new stake in Procter & Gamble during the fourth quarter worth approximately $29,000. Transcendent Capital Group LLC acquired a new position in Procter & Gamble in the fourth quarter valued at approximately $31,000. Ruedi Wealth Management Inc. boosted its holdings in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after buying an additional 77 shares in the last quarter. Finally, Criterion Capital Advisors LLC acquired a new position in shares of Procter & Gamble during the 4th quarter valued at $33,000. Institutional investors own 65.77% of the company’s stock.

Insider Activity

In other Procter & Gamble news, CEO Sundar G. Raman sold 31,924 shares of the firm’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the completion of the sale, the chief executive officer now directly owns 19,042 shares in the company, valued at approximately $3,179,061.90. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Procter & Gamble news, CEO R. Alexandra Keith sold 3,373 shares of the company’s stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $170.00, for a total transaction of $573,410.00. Following the transaction, the chief executive officer now owns 21,513 shares in the company, valued at approximately $3,657,210. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Sundar G. Raman sold 31,924 shares of Procter & Gamble stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the completion of the sale, the chief executive officer now owns 19,042 shares of the company’s stock, valued at $3,179,061.90. The disclosure for this sale can be found here. Insiders sold 116,313 shares of company stock worth $19,703,643 over the last three months. 0.17% of the stock is currently owned by corporate insiders.

Procter & Gamble Trading Down 0.0 %

PG stock traded down $0.03 during trading on Friday, reaching $167.89. The company had a trading volume of 5,640,925 shares, compared to its average volume of 6,674,588. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $171.72. The business has a 50 day moving average of $166.99 and a 200 day moving average of $163.22. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The company has a market cap of $396.24 billion, a P/E ratio of 27.43, a PEG ratio of 3.70 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. During the same quarter in the previous year, the firm posted $1.37 earnings per share. Procter & Gamble’s quarterly revenue was down .1% on a year-over-year basis. As a group, sell-side analysts forecast that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were paid a $1.0065 dividend. The ex-dividend date was Friday, July 19th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.40%. Procter & Gamble’s dividend payout ratio is currently 65.69%.

Wall Street Analyst Weigh In

PG has been the subject of a number of research analyst reports. StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. BNP Paribas assumed coverage on shares of Procter & Gamble in a report on Monday, June 24th. They set an “outperform” rating and a $187.00 price objective for the company. Dbs Bank cut Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Argus upped their price target on shares of Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Thursday, April 25th. Finally, Barclays reduced their price target on Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating for the company in a research report on Thursday, August 1st. Nine equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus target price of $173.95.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.